Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

STEMI in Coronary Dissections. When Should We Do It and What Are Its Outcomes?

Courtesy of Dr. Carlos Fava.

Generally, coronary artery dissection (SCAD) is not very frequent in young women and presents better evolution with medical treatment. However, it is occasionally associated with ST segment elevation. In this scenario, PCI with stent implantation is quite challenging.

infarto peri-procedimiento

The study looked at 4298 STEMI patients; 53 presented SCAD (1.23%).

STEMI-SCAD patients tended to be younger, were mostly women, had better BMI and fewer heart disease risk factors, but also had 2 times more cardiogenic shock (18.9% vs. 9.1% p=0.002).

13% of MI-SCAD patients were pregnant.


Read also: MitraClip in the Real World: Mid-Term Progress.


The culprit artery in this group was often the left main or the anterior descending.

Revascularization rate was lower also in this group: 70% vs. 97% (p<0.001). 31 patients received PCI with stent, 3 patients PCI with balloon and other 3 CABG.

The need for PCI was associated to cardiogenic shock, left main dissection, proximal dissection or TIMI flow 0-1.

PCI success was 91%. In addition, they received more stenting, and with longer stents.


Read also Is Complete Revascularization the Right Choice in Acute Myocardial Infarction with Multivessel Disease?


Survival at 3 years was higher in the STEMI-SCAD group: 97% vs. 84% (p<0.001).

Conclusion

STEMI-SCAD represents an important group, particularly among young women, characterized by presenting a compromised left main and cardiogenic shock more often, compared against STEMI-atherosclerosis. PCI is successful in most of these patients, with low mortality at 3 years.

Courtesy of Dr. Carlos Fava.

Original title: Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction.

Refernce: Angie S. Lobo, et al. J Am Coll Cardiol 2019;74:1290–300.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...